Monopar Therapeutics
MNPR
MNPR
4 hedge funds and large institutions have $439K invested in Monopar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$272K | |
| 2 | +$222K | |
| 3 | +$31.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$26.9K |
Top Sellers
No sellers this quarter